Search Within

Sarat Chandarlapaty

  1. "Dilip Giri"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Breast Medicine Service (7)
  3. Department of Medicine (7)
  4. Department of Pathology and Laboratory Medicine (7)
  5. GSK Faculty (7)
  6. Human Oncology and Pathogenesis Program (7)

More Groups

People
  1. Dilip Giri (7)
  2. Neal Rosen (7)
  3. Rita Sakr (6)
  4. Tari King (6)
  5. Monica Morrow (4)
  6. Victor Andrade (4)

More People

Years
  1. 2017 (1)
  2. 2014 (1)
  3. 2012 (3)
  4. 2011 (1)
  5. 2010 (1)
Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (2)
  3. European Journal of Cancer (1)
  4. Oncogene (1)
Publishers
  1. American Association for Cancer Research (5)
  2. Elsevier Inc. (1)
  3. Nature Publishing Group (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
    Journal Article

    Yang, C.; Li, Z.; Bhatt, T.; Dickler, M.; Giri, D.; Scaltriti, M.; Baselga, J.; Rosen, N.; Chandarlapaty, S.
    Oncogene (2017)

    Fulltext@MSK | Save
  • PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma
    Journal Article

    Sakr, R. A.; Weigelt, B.; Chandarlapaty, S.; Andrade, V. P.; Guerini Rocco, E.; Giri, D.; Ng, C. K. Y.; Cowell, C. F.; Rosen, N.; Reis-Filho, J. S.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Molecular predictors for type of recurrence following conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Chandarlapaty, S.; Giovanni, C.; Giri, D.; Heguy, A.; De Brot, M.; Olvera, N.; Muhsen, S.; Koslow, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Muhsen, S.; Chandarlapaty, S.; Giri, D.; Olvera, N.; Paik, W.; Goldberg, J. I.; Van Zee, K. J.; Rosen, N.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • PI3K mutations are more common in low grade DCIS
    Meeting Abstract

    Sakr, R.; Chandarlapaty, S.; Andrade, V.; Giri, D.; Muhsen, S.; Paik, W.; Morrow, M.; Rosen, N.; King, T.
    Cancer Research (2010)

    Fulltext@MSK | Save